Trends in the mortality burden associated with diabetes mellitus: A population-based study in Rochester, Minn, 1970-1994

Archives of Internal Medicine

Volumn 163, Issue 4, 2003, Pages 445-451

  Thomas, Randal J ^a   Palumbo, Pasquale J ^b   Melton III, L Joseph ^a   Roger, Véronique L ^a   Ransom, Jeanine ^a   O'Brien, Peter C ^a   Leibson, Cynthia L ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; DIABETES MELLITUS; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; POISSON DISTRIBUTION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICS;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MINNESOTA; MORTALITY; PREVALENCE; UNITED STATES;

EID: 0037463674     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.4.445     Document Type: Article

References (34)

1. Sarti C, Rastenyte D, Cepaitis Z, Tuomilehto J. International trends in mortality from stroke, 1968 to 1994. Stroke. 2000;31:1588-1601.
2. National Center for Health Statistics, Health, United States, 2000 With Adolescent Health Chartbook. Hyattsville, Md: National Center for Health Statistics; 2000.
3. Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke. 1996;27:373-380.
4. McGovern PG, Pankow JS, Shahar E, et al, for The Minnesota Heart Survey Investigators. Recent trends in acute coronary heart disease - mortality, morbidity, medical care, and risk factors. N Engl J Med. 1996;334:884-890.
5. Sytkowski PA, D'Agostino RB, Belanger A, Kannel WB. Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study, 1950-1989. Am J Epidemiol. 1996;143:338-350.
6. Shahar E, McGovern PG, Sprafka JM, et al. Improved survival of stroke patients during the 1980s: the Minnesota Stroke Survey. Stroke. 1995;26:1-6.
7. Leibson CL, O'Brien PC, Atkinson E, Palumbo PJ, Melton LJ III. Relative contributions of incidence and survival to increasing prevalence of adult-onset diabetes mellitus: a population-based study. Am J Epidemiol. 1997;146:12-22.
8. Seidell JC. Obesity, insulin resistance and diabetes: a worldwide epidemic. Br J Nutr. 2000;83(suppl 1):S5-S8.
9. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21:518-524.
10. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281:1291-1297.
11. Quenana L, Remington JP. Diabetes mortality trends in Wisconsin, 1979-1997: the increasing gap between whites and blacks. WMJ. 2000;99:44-47.
12. National Center for Chronic Disease Prevention and Health Promotion. Statistics diabetes surveillance, 1999. Available at: http://www.cdc.gov/diabetes /statistics. Accessed November 7, 2002.
13. Geiss LS, Herman WH, Smith PJ. Mortality in non-insulin-dependent diabetes. In: National Diabetes Data Group Diabetes in America. 2nd ed. Bethesda, Md: National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health; 1995:233-258. NIH publication 95-1468.
14. Bild DE, Stevenson JM. Frequency of recording of diabetes on US death certificates: analysis of the 1986 National Mortality Followback Survey. J Clin Epidemiol. 1992;45:275-281.
15. Ochl JW, Melton LJ III, Palumbo PJ, Chu CP. A population-based study of diabetes mortality. Diabetes Care. 1985;8:224-229.
16. Vauzelle-Kervroedan F, Delcourt C, Forhan A, Jougla E, Hatton F, Papoz L. Analysis of mortality in French diabetic patients from death certificates: a comparative study. Diabetes Metab. 1999;25:404-411.
17. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71:266-274.
18. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039-1057.
19. West KM. Standardization of definition, classification, and reporting in diabetes-related epidemiologic studies. Diabetes Care. 1979;2:65-76.
20. Palumbo PJ, Elveback LR, Chu CP, Connolly DC, Kurland LT. Diabetes mellitus: incidence, prevalence, survivorship, and causes of death in Rochester, Minnesota, 1945-1970. Diabetes. 1976;25:566-573.
21. Melton LJ 3d, Palumbo PJ, Dwyer MS, Chu C-P. Impact of recent changes in diagnostic criteria on the apparent natural history of diabetes mellitus. Am J Epidemiol. 1983;117:559-565.
22. Melton LJ, Palumbo PJ, Chu C-P. Incidence of diabetes mellitus by clinical type. Diabetes Care. 1983;6:75-86.
23. Burke JR, O'Brien P, Ransom J, et al. An update of the incidence of diabetes in Rochester, Minnesota, through 1994: contemporaneous trends in ascertainment. Diabetes Care. Am J Epidemiol. 2002;155:859-865.
24. Bergstralh EJ, Offord KP, Chu C-P, et al. Calculating Incidence, Prevalence and Mortality Rates for Olmsted County, Minnesota: An Update. Rochester, Minn: Mayo Clinic Foundation; 1992. Technical Report 49.
25. Anderson GL, Whisnant JP. A comparison of trends in mortality from stroke in the United States and Rochester, Minnesota. Stroke. 1982;13:804-809.
26. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1197.
27. Tuomilehto J, Lindstrom J, Eriksson JG, et al, for the Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350.
28. Narayan KM, Thompson TJ, Boyle JP, et al. The use of population attributable risk to estimate the impact of prevention and early detection of type 2 diabetes on population-wide mortality risk in US males. Health Care Manag Sci. 1999;2: 223-227.
29. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet. 2000;355:253-259.
30. Clarke P, Gray A, Adler A, et al, for the UKPDS Group. United Kingdom Prospective Diabetes Study: cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51). Diabetologia. 2001;44:298-304.
31. Grover SA, Coupal L, Zowall H, Dorais M. Cost-effectiveness of treating hyperlipidemia in the presence of diabetes: who should be treated? Circulation. 2000; 102:722-727.
32. Messeril FH, Grossman E, Goldbourt U. Antihypertensive therapy in diabetic hypertensive patients. Am J Hypertens. 2001;14(pt 2):12S-16S.
33. Leibson CL, Baccarelli A, O'Brien P, Brown RD Jr, Melton LJ III, Palumbo PJ. Temporal trends in elevated blood pressure for persons with diabetes: a population-based study [abstract]. Diabetes. 2000;49:A187.
34. Abu-Lebdeh HS, Hodge DO, Nguyen TT. Predictors of macrovascular disease in patients with type 2 diabetes mellitus. Mayo Clin Proc. 2001;76:707-712.